Cargando…
COVID-19 and antimalarials. Have we been doing it wrong all along?
In the context of the current SARS-CoV-2 pandemic, associations of drugs which interfere with specific steps of the viral infectious cycle are currently being exploited as therapeutic strategies since a specific treatment by vaccination is still unavailable. A widespread association of repurposed ag...
Autores principales: | Cismaru, Cosmin Andrei, Cismaru, Gabriel Laurentiu, Seyed Nabavi, Fazel, Seyed Nabavi, Mohammad, Berindan-Neagoe, Ioana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7604012/ https://www.ncbi.nlm.nih.gov/pubmed/33130275 http://dx.doi.org/10.1016/j.ejphar.2020.173694 |
Ejemplares similares
-
Game of “crowning” season 8: RAS and reproductive hormones in COVID-19 – can we end this viral series?
por: Cismaru, Andrei Cosmin, et al.
Publicado: (2020) -
Multiple potential targets of opioids in the treatment of acute respiratory distress syndrome from COVID‐19
por: Cismaru, Cosmin Andrei, et al.
Publicado: (2020) -
Possible use of the mucolytic drug, bromhexine hydrochloride, as a prophylactic agent against SARS-CoV-2 infection based on its action on the Transmembrane Serine Protease 2
por: Habtemariam, Solomon, et al.
Publicado: (2020) -
Glucose-6-phosphate dehydrogenase deficiency and SARS-CoV-2 mortality: Is there a link and what should we do?
por: Nabavi, Seyed Fazel, et al.
Publicado: (2020) -
Lessons from SARS and MERS remind us of the possible therapeutic effects of implementing a siRNA strategy to target COVID‐19: Shoot the messenger!
por: Habtemariam, Solomon, et al.
Publicado: (2020)